Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Microbiol Immunol Infect ; 55(2): 336-340, 2022 Apr.
Article in English | MEDLINE | ID: mdl-34565695

ABSTRACT

We investigated the incidence of 15 respiratory viruses among 2991 children with acute respiratory infections in Novosibirsk city, Russia, prior to the COVID-19 pandemic (2013-2020). Viral infections were detected in 72.5% cases. The incidence of human coronavirus was 2% (Alphacoronaviruses, 63%; Betacoronaviruses, 37%).


Subject(s)
COVID-19 , Respiratory Tract Infections , COVID-19/epidemiology , Child , Child, Hospitalized , Hospitalization , Humans , Incidence , Pandemics , Respiratory Tract Infections/epidemiology , SARS-CoV-2
2.
Bull Exp Biol Med ; 165(2): 248-251, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29923002

ABSTRACT

Antiviral efficiency of oxidized dextrans (OD) with different molecular weights and oxidation degree (OD40min, OD70min, OD40max, and OD70 max) was studied in vitro and in vivo. Dextrans OD40max and OD70max prevented the development of the cytopathic effect of influenza A(H1N1)pdm09 virus in more than 50% MDCK cells vs. control (no OD). Four intranasal doses of OD40min, OD40max, and OD70min and one intranasal dose of OD70max before infection of BALB/c mice with A(H1N1)pdm09 influenza virus significantly reduced mortality and prolonged life span in comparison with controls receiving saline. These and our previous data attest to clear-cut preventive effect of OD in influenza infection.


Subject(s)
Antiviral Agents/pharmacology , Dextrans/pharmacology , Influenza A Virus, H1N1 Subtype/drug effects , Orthomyxoviridae Infections/prevention & control , Animals , Antiviral Agents/therapeutic use , Dextrans/chemistry , Dextrans/therapeutic use , Dogs , Female , Madin Darby Canine Kidney Cells , Male , Mice , Mice, Inbred BALB C/abnormalities , Oxidation-Reduction
SELECTION OF CITATIONS
SEARCH DETAIL
...